Los Angeles Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,390
| Closed | -$228K | – | 1162 |
|
|
2024
Q4 | $228K | Sell |
6,390
-1,196
| -16% | -$42.8K | ﹤0.01% | 1017 |
|
|
2024
Q3 | $358K | Buy |
7,586
+569
| +8% | +$26.9K | ﹤0.01% | 955 |
|
|
2024
Q2 | $353K | Sell |
7,017
-870
| -11% | -$43.7K | ﹤0.01% | 960 |
|
|
2024
Q1 | $883K | Sell |
7,887
-12
| -0.2% | -$1.34K | ﹤0.01% | 728 |
|
|
2023
Q4 | $458K | Hold |
7,899
| – | – | ﹤0.01% | 897 |
|
|
2023
Q3 | $251K | Buy |
+7,899
| New | +$251K | ﹤0.01% | 1010 |
|
|
2023
Q2 | – | Sell |
-2,472
| Closed | -$254K | – | 1239 |
|
|
2023
Q1 | $254K | Buy |
2,472
+429
| +21% | +$44.1K | ﹤0.01% | 1065 |
|
|
2022
Q4 | $299K | Sell |
2,043
-2,458
| -55% | -$360K | ﹤0.01% | 1037 |
|
|
2022
Q3 | $761K | Buy |
+4,501
| New | +$761K | ﹤0.01% | 790 |
|
|
2020
Q3 | – | Sell |
-1,314
| Closed | -$768K | – | 1485 |
|
|
2020
Q2 | $768K | Buy |
1,314
+418
| +47% | +$244K | ﹤0.01% | 948 |
|
|
2020
Q1 | $131K | Buy |
+896
| New | +$131K | ﹤0.01% | 1266 |
|